Pang T, Blanden R V
J Exp Med. 1976 Mar 1;143(3):469-81. doi: 10.1084/jem.143.3.469.
Spleen cells and serum from mice immunized with ectromelia virus suppressed the immune response to infectious virus when transferred intravenously into recipient mice given an immunizing virus dose. The suppression was reflected in decreased cytotoxic T-cell activity directed against H-2 compatible virus-infected target cells in the spleens of recipients. Suppression was observed when immune cells or serum were transferred 1-2 h or 1 day after immunization of recipients, but not 2 days after, and was maximal when 6-day immune spleen cells were used as suppressor cells. H-2 compatibility between donor and recipient mice was necessary for suppression to be expressed. Use of recombinant mice showed that I-region compatibility was neither sufficient nor necessary, and that D-region compatibility was sufficient. Specificity of suppression was suggested by the finding that cells and serum from mice immunized with Listeria monocytogenes, a bacterium, had no suppressive activity on the antiviral response. Anti-theta treatment eliminated the ability of immune cells to suppress, and the suppressive effect was not markedly dose-dependent with respect to both cell dose and virus dose under the conditions employed. Virus levels in the spleens of recipients were significantly reduced after injection of immune cells. Adult thymectomy had no effect on the primary immune response to ectromelia virus infection, thus indicating no role for T1 cells in the suppressive mechanism. The results obtained therefore suggested that suppression in this system was due to effector T cells which triggered clearance of virus (and thus, of virus-induced antigens) necessary for the induction of precursors of effector T cells, and that this simple feed-back mechanism normally plays an important role in the regulation of the primary immune response to ectromelia infection at the level of precursor induction. The existence of other postinduction regulatory mechanisms, however, is unknown and under investigation.
用痘苗病毒免疫的小鼠的脾细胞和血清,在静脉注射给接受免疫剂量病毒的受体小鼠后,抑制了对感染性病毒的免疫反应。这种抑制表现为受体小鼠脾脏中针对H-2相容的病毒感染靶细胞的细胞毒性T细胞活性降低。当在受体小鼠免疫后1-2小时或1天转移免疫细胞或血清时观察到抑制作用,但在免疫后2天未观察到,当使用6天免疫的脾细胞作为抑制细胞时抑制作用最大。供体和受体小鼠之间的H-2相容性是表达抑制作用所必需的。使用重组小鼠表明,I区相容性既不充分也不必要,而D区相容性是充分的。用单核细胞增生李斯特菌(一种细菌)免疫的小鼠的细胞和血清对抗病毒反应没有抑制活性,这一发现提示了抑制作用的特异性。抗θ处理消除了免疫细胞的抑制能力,在所采用的条件下,抑制作用在细胞剂量和病毒剂量方面均无明显的剂量依赖性。注射免疫细胞后,受体小鼠脾脏中的病毒水平显著降低。成年胸腺切除对痘苗病毒感染的初次免疫反应没有影响,因此表明T1细胞在抑制机制中不起作用。因此,所获得的结果表明,该系统中的抑制作用是由于效应T细胞触发了病毒(以及因此病毒诱导的抗原)的清除,而这是效应T细胞前体诱导所必需的,并且这种简单的反馈机制通常在痘苗感染初次免疫反应的前体诱导水平的调节中起重要作用。然而,其他诱导后调节机制的存在尚不清楚,正在研究中。